Join our expert panel for an industry discussion
In the last year, clinical trial operations were forced to welcome alternative technological approaches to alleviate disruptions from the global pandemic. With the dust settled a bit and a taste of the increased efficiency and visibility offered by these approaches, many are considering how to leverage this momentum to optimize use of technology beyond disruption management. But the question is how can all study stakeholders - patients, sponsors, investigators and staff - benefit from the efficiency, transparency, and visibility that technology offers?
This session is designed to equip senior leadership in clinical operations with a framework to select and evaluate innovation and manage change to optimize clinical trials not only for today but with lasting effect for the future. Rather than reviewing tactical decisions about point solutions, this session will give you tips and insights from key trial stakeholders on how to ensure your evaluation of technology starts with the end in mind and supports faster, safer, more efficient clinical trials.
Malia Lewin, Teckro global head of strategy will moderate the session.
Lydia Beaudette, manager of growth & strategic partnerships at LMC Manna Research will be a panelist.